Aids Malignancy Consortium

This study is testing whether the drug ixazomib can shrink Kaposi sarcoma skin tumors. It will involve 41 adults with measurable skin lesions, including people living with HIV. Participants will take the drug orally in cycles for up to a year to see if it controls the cancer and …

This early-stage study is testing a personalized immune therapy called axicabtagene ciloleucel (a type of CAR-T) for people with HIV who have an aggressive form of B-cell lymphoma that has returned or not responded to prior treatments. The main goals are to check if the treatment…

This study is testing whether a special smartphone app designed for people with HIV can help them quit smoking when it's used alongside a lung cancer screening scan. Researchers want to see if 100 participants will use the app and complete the scan, and if this combined approach …